PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-118
Closed -$11.2K 381
2024
Q1
$11.2K Hold
118
0.01% 274
2023
Q4
$10.5K Buy
+118
New +$8.76K 0.01% 246

Other funds holding XBI

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s XBI Position: Q2 2024 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 118 shares — an estimated $11.2K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in XBI in Q4 2023 and held it in 2 quarters. The position peaked at $11.2K in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 118 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $11.2K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 2 quarters.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s State Street SPDR S&P Biotech ETF position peaked at $11.2K in Q1 2024.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2024, filed 7 Aug 2026.